- Home
- YORW vs PSNL Comparison
YORW vs PSNL Comparison
Compare YORW & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YORW
- PSNL
- Stock Information
- Founded
- YORW 1816
- PSNL 2011
- Country
- YORW United States
- PSNL United States
- Employees
- YORW N/A
- PSNL N/A
- Industry
- YORW Water Supply
- PSNL Medical Specialities
- Sector
- YORW Utilities
- PSNL Health Care
- Exchange
- YORW Nasdaq
- PSNL Nasdaq
- Market Cap
- YORW 450.1M
- PSNL 460.7M
- IPO Year
- YORW N/A
- PSNL 2019
- Fundamental
- Price
- YORW $33.11
- PSNL $4.72
- Analyst Decision
- YORW
- PSNL Strong Buy
- Analyst Count
- YORW 0
- PSNL 4
- Target Price
- YORW N/A
- PSNL $7.81
- AVG Volume (30 Days)
- YORW 52.9K
- PSNL 1.1M
- Earning Date
- YORW 03-04-2025
- PSNL 02-27-2025
- Dividend Yield
- YORW 2.65%
- PSNL N/A
- EPS Growth
- YORW N/A
- PSNL N/A
- EPS
- YORW 1.48
- PSNL N/A
- Revenue
- YORW $74,189,000.00
- PSNL $87,489,000.00
- Revenue This Year
- YORW $7.70
- PSNL $16.00
- Revenue Next Year
- YORW $5.33
- PSNL $1.29
- P/E Ratio
- YORW $22.39
- PSNL N/A
- Revenue Growth
- YORW 9.03
- PSNL 24.05
- 52 Week Low
- YORW $29.86
- PSNL $1.14
- 52 Week High
- YORW $41.96
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- YORW 60.24
- PSNL 43.46
- Support Level
- YORW $30.46
- PSNL $4.47
- Resistance Level
- YORW $32.03
- PSNL $6.43
- Average True Range (ATR)
- YORW 0.60
- PSNL 0.51
- MACD
- YORW 0.27
- PSNL 0.00
- Stochastic Oscillator
- YORW 78.87
- PSNL 12.50
About YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and two wastewater treatment systems. The company operates within its franchised territory, which covers more than 54 municipalities within York County, Pennsylvania.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.